Paronychia
BASICS
DESCRIPTION
- Superficial inflammation of the lateral and posterior nail folds surrounding the fingernail or toenail. Develops after breakdown of barrier between nail plate and the adjacent nail fold
- Acute: characterized by pain, erythema, and swelling (1) lasting <6 weeks; usually a bacterial infection appearing after nail biting, trauma, manicures, ingrown nails, and hangnail manipulation. It also occurs as an adverse effect from several drugs. It can progress to abscess formation.
- Chronic: characterized by swelling, tenderness, cuticle elevation, and nail dystrophy and separation lasting at least 6 weeks, or recurrent episodes of acute eponychial inflammation and drainage
- Chemotherapy-associated paronychia (CAP) starts 4 to 8 weeks after chemotherapy initiation (2).
- May be considered work-related among bartenders, restaurant servers, dishwashers, nurses, and others who often wash their hands
- Usually involves one finger but drug-induced paronychia may involve multiple fingers
- Relevant anatomy: nail bed, nail plate, and perionychium
- Synonym(s): eponychia, perionychia, retronychia
Pediatric Considerations
Less common in pediatric age groups; commonly caused by trauma to periungual skin, such as thumb/finger-sucking or other injuries (Staphylococcus aureus and group A Streptococcus may be present). Paronychia is also a frequent adverse effect of BRAF and MEK inhibitor anticancer drugs.
EPIDEMIOLOGY
Incidence
- One of the most common hand infections in the United States
- Predominant age: all ages
- Predominant sex: female > male
ETIOLOGY AND PATHOPHYSIOLOGY
- Acute: mixed aerobic and anaerobic bacterial flora in 50% of cases. Staphylococcus aureus most common and Streptococcus pyogenes; less frequently, Pseudomonas aeruginosa and other gram-negative bacteria (with chronic paronychia)
- Chronic: eczematous reaction with secondary Candida albicans (~95%)
- Pediatric age groups: mixed anaerobic (Fusobacterium, Peptostreptococcus) and aerobic infections (Eikenella corrodens, S. aureus, streptococci) from oral flora
- A paronychial infection commonly starts in the lateral nail fold.
- Acute paronychia of the fingers is often due to trauma; acute paronychia of the toes is often due to ingrown nails (3).
- Recurrent inflammation, persistent edema, and fibrosis of nail folds cause nail folds to round up and retract, exposing nail grooves to irritants, allergens, and pathogens.
- Inflammation compromises ability of proximal nail fold to regenerate cuticle leading to decreased vascular supply. This can cause decrease efficacy of topical medications.
- Early in the course, cellulitis alone may be present.
- An abscess can form if the infection does not resolve quickly.
RISK FACTORS
- Acute: direct or indirect trauma to cuticle or nail fold, manicured/sculptured nails, nail biting, thumb sucking, manipulating a hangnail, ingrown toenail
- Chronic: frequent immersion of hands in water with excoriation of the lateral nail fold (e.g., chefs, bartenders, housekeepers, swimmers, dishwashers, nurses)
- Predisposing conditions such as diabetes mellitus (DM) and immunosuppression
- Medications such as EGFR inhibitors, systemic retinoids, chemotherapy, and antiretroviral agents
GENERAL PREVENTION
- Acute: Avoid trauma such as nail biting or manipulating a hangnail. Prevent ingrown toenails.
- Chronic: Avoid exposure to allergens and contact irritants; keep fingers/hands dry; wear rubber gloves with a cotton liner. Prevent excoriation of the skin.
- Keep nails short; avoid manicures.
- Apply moisturizer after washing hands.
COMMONLY ASSOCIATED CONDITIONS
DM, eczema or atopic dermatitis, immunosuppression
DIAGNOSIS
HISTORY
- Localized pain or tenderness, swelling, and erythema of posterior or lateral nail folds
- Acute: fairly rapid onset (2 to 5 days after trauma)
- Chronic: at least 6 weeks’ duration
- Previous trauma (i.e., bitten nails, ingrown nails, manicured nails)
- Contact with herpes infections
- Contact with allergens or irritants (frequent water immersion, latex)
- Immunosuppressive therapy
PHYSICAL EXAM
- Acute: red, warm, tender, tense posterior or lateral nail fold ± abscess
- Chronic:
- Initially appears as swollen, tender, boggy nail fold ± abscess
- Later appears as retraction of nail fold and absence of adjacent healthy cuticle, thickening of nail plate with prominent transverse ridges known as Beau lines and discoloration; multiple digits typically involved
- Occasional elevation of nail bed or separation of nail fold from nail plate
- Fluctuance, purulence at the nail margin, or purulent drainage
- An untreated infection of the toe may lead to the formation of granulation tissue around the nail fold (3).
- Secondary changes of nail platelike discoloration
- Suspect Pseudomonas if with green changes in nail (chloronychia).
DIFFERENTIAL DIAGNOSIS
- Felon (abscess of fingertip pulp; urgent diagnosis required)
- Cellulitis
- Eczema
- Herpetic whitlow (similar in appearance, very painful, often associated with vesicles)
- Allergic contact dermatitis (latex, acrylic)
- Psoriasis (especially acute flare)
- Proximal/lateral onychomycosis (nail folds not predominantly involved)
- Retronychia
- Pemphigus vulgaris
- Acute osteomyelitis of the distal phalanx
- Reiter disease
- Pustular psoriasis
- Dermatomyositis
- Malignancy: squamous cell carcinoma of the nail, malignant melanoma, metastatic disease
DIAGNOSTIC TESTS & INTERPRETATION
None required unless condition is severe; resistant to treatment or if recurrence or methicillin-resistant S. aureus (MRSA) is suspected, then
- Gram stain
- Culture and sensitivity
- Potassium hydroxide wet mount plus fungal culture especially in chronic paronychia
- Drugs that may alter lab results: use of over-the-counter antimicrobials or antifungals
Initial Tests (lab, imaging)
Consider ultrasonography if uncertain about presence of an abscess.
Diagnostic Procedures/Other
- Incision and drainage recommended for suppurative cases or cases not responding to conservative management or empiric antibiotics
- Tzanck testing or viral culture in suspected viral cases
- Biopsy in cases not responding to conservative management or when malignancy suspected
TREATMENT
GENERAL MEASURES
- Acute inflammation without abscess: warm water soaks or antiseptic soaks, and topical antibiotics (2). Consider oral antibiotics for more severe cases that do not respond to topical treatment alone.
- Abscesses should be drained.
- Antibiotics may not be necessary for successful I&D of uncomplicated infections.
- Chronic: Keep fingers dry; apply moisturizing lotion after hand washing; avoid exposure to irritants; improved diabetic control
- Pediatric cases should be treated with systemic antibiotics.
MEDICATION
First Line
- Acute paronychia (mild cases, no abscess formation):
- Warm water soaks or antiseptic soaks (chlorhexidine, povidone-iodine) multiple times a day for 10 to 15 minutes each time, and topical antibiotics with S. aureus coverage (triple antibiotic ointment, mupirocin, bacitracin)
- Antibiotic cream applied TID–QID after warm soak for 5 to 10 days
- If eczematous: high-potency topical steroid applied BID (e.g., betamethasone 0.05% cream) for 7 to 14 days
- Acute paronychia (no abscess formation, not responding to topical treatment). Treat for 5 to 7 days.
- Dicloxacillin 250 mg QID
- Cephalexin 500 mg TID–QID
- Acute paronychia (exposure to oral flora, no abscess formation). Treat for 7 days. Cover for Eikenella.
- Amoxicillin-clavulanate: 875 mg/125 mg BID; pediatric, 45 mg/kg q12h (for <40 kg) or
- One of the following for Eikenella coverage:
- Doxycycline 100 mg BID
- Trimethoprim/sulfamethoxazole BID
- Penicillin VK 500 mg QID
- Ciprofloxacin 500 to 750 mg BID (Reserve fluoroquinolones for severe infection due to risks from this class of antibiotic.)
- PLUS one of the following for anaerobic coverage:
- Clindamycin 450 mg TID (pediatric, 10 mg/kg q8h)
- Metronidazole 500 mg TID
- Acute paronychia (with risk factors for MRSA including but not limited to: recent hospitalization, recent surgery, ESRD on hemodialysis, HIV/AIDS, IVDU, resident of long term care facility). Treat for 7 days.
- Trimethoprim/sulfamethoxazole 160 mg/800 mg BID
- Doxycycline 100 mg BID
- Clindamycin 300 to 450 mg TID–QID
- Acute paronychia with abscess formation:
- Incision and drainage
- Consider digital block anesthesia. Then, insert nail elevator, #11 scalpel blade, or hypodermic needle along nail plate at junction of the affected nail fold and nail to facilitate drainage. If no drainage occurs, use a needle or scalpel to open skin directly above abscess.
- If ingrown nail involved or abscess extends to nail bed, consider partial nail removal.
- Consider oral antibiotics for extension of cellulitis. Otherwise, usually no antibiotics indicated after I&D
- Incision and drainage
Pediatric Considerations
- Without abscess formation: use systemic antibiotics as first-line treatment. Empiric treatment with beta-lactamase-resistant antibiotics (e.g., dicloxacillin, cloxacillin).
- With abscess formation: incision and drainage
- Chronic paronychia: Stop source of irritation, control inflammation, and restore natural protective barrier.
- Topical high-potency steroids: betamethasone 0.05%; applied BID for 7 to 14 days
- Topical antifungal: clotrimazole or nystatin; applied topically TID for up to 30 days
- Topical calcineurin inhibitor: Tacrolimus 0.1% ointment BID for up to 21 days has been shown to be more effective than betamethasone but is more expensive.
- For paronychia caused by EGFR inhibitors, treat with topical antibiotics and potent topical corticosteroids without discontinuing the EGFR inhibitor for mild cases. For more severe cases, discontinue EGFR inhibitor temporarily.
- For paronychia caused by oncology pharmacotherapy, treat with corticosteroid ointment and phenol chemical matricectomy. Prompt treatment enables patients to continue anticancer drug treatment without impairing their quality of life.
Second Line
- Systemic antifungals (rarely needed, use if topical fails)
- Itraconazole 200 mg for 90 days (may have longer action because it is incorporated into nail plate); pulse therapy may be useful (i.e., 200 mg BID for 7 days, repeated monthly for 2 months).
- Terbinafine 250 mg/day for 6 weeks (fingernails) or 12 weeks (toenails)
- Fluconazole 100 mg daily for 7 to 14 days
- Ciclopirox 0.77% topical suspension BID for 2 to 4 weeks along with strict irritant avoidance
- Antipseudomonal drugs (e.g., ceftazidime, aminoglycosides) when pseudomonas is suspected
ISSUES FOR REFERRAL
- Acute: Severe infection may spread to underlying tendons, requiring evaluation and treatment by a hand surgeon as it often involves débridement, washout, or amputation, based on the severity of the infection.
- Chronic: In treatment failure, consider biopsy and/or, in cases of chronic paronychia, referral for possible partial excision of the nail fold or eponychial marsupialization with or without complete nail removal or Swiss roll technique.
- Failure to respond to therapy or chronic redness, tenderness and swelling of nail folds without abscess can be concerning for malignancy. Consider biopsy (3).
ADDITIONAL THERAPIES
Topical betaxolol 0.25% eye drops once daily on paronychia and pyogenic granuloma-like lesions covered with bandage
SURGERY/OTHER PROCEDURES
- Incision and drainage of abscess, if present. A subungual abscess or ingrown nail requires partial or complete removal of nail with phenolization of germinal matrix.
- Swiss roll technique for chronic and severe acute paronychia with runaround abscess involving both nail folds
- Recalcitrant cases may also need nail removal.
COMPLEMENTARY & ALTERNATIVE MEDICINE
Nail braces as a noninvasive alternative to nail extraction for patients with severe paronychia induced by EGFR inhibitors
ONGOING CARE
FOLLOW-UP RECOMMENDATIONS
- Acute: Postdrainage care consists of warm soaks or antiseptic soaks. Follow up in 24 to 48 hours after I&D to monitor for worsening infection.
- Chronic: Avoid frequent immersion, triggers, allergens, nail biting, or finger sucking.
DIET
Maintain good glucose control.
PATIENT EDUCATION
- Avoid trimming cuticles; avoid nail trauma; and stress importance of good diabetic control and diabetic education.
- Avoid contact irritants; use rubber gloves with cotton liners to avoid exposure to excess moisture.
- Use moisturizing lotion after washing hands; do not bite nails/suck on fingers.
PROGNOSIS
- With adequate treatment and prevention, healing can be expected in 1 to 2 weeks.
- Chronic paronychia may respond slowly to treatment, taking weeks to months.
- If no response in chronic lesions, rarely benign or malignant neoplasm may be present and referral to dermatology should be considered.
COMPLICATIONS
- Acute: subungual abscess
- Chronic: nail thickening, discoloration of nail, and nail loss
Figures
Figure 13-9
Acute paronychia. Note erythema and edema of the proximal nail fold.
Figure 13-10
Chronic paronychia. In addition to erythema and edema, you can also observe nail dystrophy, the absence of a cuticle.
Authors
Nancy V. Nguyen, DO
REFERENCES
- [PMID:28671378] . Acute and chronic paronychia. Am Fam Physician. 2017;96(1):44–51.
- [PMID:35655642] , . Acute and chronic paronychia revisited: a narrative review. J Cutan Aesthet Surg. 2022;15(1):1–16.
- [PMID:27810017] , , . Toenail paronychia. Foot Ankle Surg. 2016;22(4):219–223.
SEE ALSO
CODES
ICD10
- L03.019 Cellulitis of unspecified finger
- L03.039 Cellulitis of unspecified toe
- L03.011 Cellulitis of right finger
- L03.012 Cellulitis of left finger
- L03.031 Cellulitis of right toe
- L03.032 Cellulitis of left toe
SNOMED
- 71906005 Paronychia (disorder)
- 444646006 Paronychia of finger
- 388983002 Paronychia of toe
CLINICAL PEARLS
- Consider incision and drainage when appropriate.
- For chronic paronychia, topical steroid is the first-line treatment. Consider other differentials in nonresponders (e.g., rare causes: Raynaud, metastatic cancer, psoriasis, drug toxicity).
- Consider presence of more than one nail disease at the same time (e.g., paronychia and onychomycosis).
Last Updated: 2026
© Wolters Kluwer Health Lippincott Williams & Wilkins